These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 14173355)

  • 1. [EXPERIMENTAL STUDIES ON EFFECT OF COMBINED USE OF 1314TH AND INH TO INH-RESISTANT TUBERCLE BACILLI. 2. COMBINATION EFFECT IN THE EXPERIMENTAL TUBERCULOSIS OF MICE].
    NOZAKI T
    Kekkaku; 1964 Jun; 39():223-7. PubMed ID: 14173355
    [No Abstract]   [Full Text] [Related]  

  • 2. [EXPERIMENTAL STUDIES ON EFFECT OF COMBINED USE OF 1314 TH AND INH TO INH-RESISTANT TUBERCLE BACILLI. I. COMBINATION EFFECT IN LIQUID MEDIUM AND IN VERTICAL DIFFUSION METHOD].
    NOZAKI T
    Kekkaku; 1964 Jun; 39():217-22. PubMed ID: 14173354
    [No Abstract]   [Full Text] [Related]  

  • 3. [EFFECTS OF ETHIONAMIDE ON TUBERCLE BACILLI RESISTANT TO VARIOUS ANTITUBERCULAR AGENTS AND THE EFFECTS OF THESE AGENTS ON ETHIONAMIDE-RESISTANT TUBERCLE BACILLI].
    TSUCHIMOCHI T
    Kekkaku; 1963 Jun; 38():264-9. PubMed ID: 14046673
    [No Abstract]   [Full Text] [Related]  

  • 4. The tate of patients with drug-resistant tubercle bacilli and pulmonary tuberculosis.
    PINES A
    Br J Dis Chest; 1962 Oct; 56():163-70. PubMed ID: 13943667
    [No Abstract]   [Full Text] [Related]  

  • 5. A COMPARATIVE STUDY OF THE SUSCEPTIBILITY TO ETHIONAMIDE, THIOSEMICARBAZONE, AND ISONIAZID OF TUBERCLE BACILLI FROM PATIENTS NEVER TREATED WITH ETHIONAMIDE OR THIOSEMICARBAZONE.
    HOK TT
    Am Rev Respir Dis; 1964 Sep; 90():468-9. PubMed ID: 14215919
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of patients harbouring tubercle bacilli resistant to isoniazid, streptomycin and PAS.
    JANCIK E
    Rev Czech Med; 1962; 8():200-13. PubMed ID: 13957320
    [No Abstract]   [Full Text] [Related]  

  • 7. STUDIES ON DRUG-RESISTANT TUBERCLE BACILLI IN EXPERIMENTAL TUBERCULOSIS. I. DEVELOPMENT OF INH-RESISTANT TUBERCLE BACILLI IN EXPERIMENTAL MURINE TUBERCULOSIS.
    HORI M; SHOJI K; YAMANOUCHI T; SAWAI A
    Jpn J Tuberc; 1963 Dec; 11():62-3. PubMed ID: 14171376
    [No Abstract]   [Full Text] [Related]  

  • 8. [COMBINATION OF ETHIONAMIDE AND P-AMINOSALICYLIC ACID IN THE TREATMENT OF PULMONARY TUBERCULOSIS WITH GERMS RESISTANT TO ISONIAZID AND STREPTOMYCIN].
    PEREZ JA; FARIAS CE; AMADIO G; CAFURE N
    Prensa Med Argent; 1963 Dec; 50():3280-1. PubMed ID: 14184234
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental studies on the effect of the combined use of 1314 Th and INH to INH-resistant tubercle bacilli from the view-point of 14C-INH uptake].
    Takae S
    Kekkaku; 1967 Apr; 42(4):119-28. PubMed ID: 4965143
    [No Abstract]   [Full Text] [Related]  

  • 10. The action of bromosalicylhydroxamic acid (T40) on the biological level of INH and on the emergence of INH-resistant bacilli in combined treatment of tuberculosis.
    HORNUNG S; POLONCZYK M; DRAJKA-KROPACZEK L; RAPF T
    Acta Tuberc Pneumol Scand; 1962; 42():233-9. PubMed ID: 13954963
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of advanced isonizid- and streptomycin-resistant pulmonary tuberculosis with ethionamide, pyrazinamide, and isoniazid.
    PETTY TL; MITCHELL RS
    Am Rev Respir Dis; 1962 Oct; 86():503-12. PubMed ID: 13942996
    [No Abstract]   [Full Text] [Related]  

  • 12. THE USE OF ETHIONAMIDE IN COMBINED DRUG REGIMENS IN THE RE-TREATMENT OF ISONIAZID-RESISTANT PULMONARY TUBERCULOSIS.
    SCHLESS JM; ALLISON RF; INGLIS RM; WHITE EF; TOPPERMAN S
    Am Rev Respir Dis; 1965 May; 91():728-37. PubMed ID: 14280946
    [No Abstract]   [Full Text] [Related]  

  • 13. "ACTUAL COUNT" METHOD FOR THE RESISTANCE TEST OF TUBERCLE BACILLI.
    TSUKAMURA M
    Jpn J Tuberc; 1964 Dec; 12():46-54. PubMed ID: 14312616
    [No Abstract]   [Full Text] [Related]  

  • 14. [ON THE INDICATIONS AND DOSAGE OF ETHIONAMIDE. DATA FROM LABORATORY EXPERIMENTATION].
    RIST N
    G Ital Chemioter; 1963; 10():83-6. PubMed ID: 14074254
    [No Abstract]   [Full Text] [Related]  

  • 15. [CLINICAL TRIAL OF 3 TYPES OF ORAL TREATMENT OF PULMONARY TUBERCULOSIS. (ISONIAZID+ETHIONAMIDE, ISONIAZID + PAS, ISONIAZID ALONE)].
    LEHIR M; CHICOU J; HETRICK G; MERCIER A; NEEL R; RIST N
    Bull World Health Organ; 1964; 30(5):701-32. PubMed ID: 14196816
    [No Abstract]   [Full Text] [Related]  

  • 16. THE GUINEA PIG VIRULENCE OF INDIAN TUBERCLE BACILLI.
    SINGH B
    Am Rev Respir Dis; 1964 Jan; 89():1-11. PubMed ID: 14114409
    [No Abstract]   [Full Text] [Related]  

  • 17. AMINO ACIDS ACTIVATION IN TUBERCULOSIS BACILLI OF VARIOUS ANTIBACILLAR DRUGS SENSIVITY.
    HIEROWSKI M; WESTFAL I
    Bull Soc Amis Sci (Med) (Poznan); 1963; 12():17-23. PubMed ID: 14104990
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical studies on ethionamide treatment of pulmonary tuberculosis. The bacteriologic effect and the resistance of tubercle bacilli to ethionamide].
    SAKURAI H; INOUE I; SASAOKA A; SUZUKI T; YAGI A; TANAKA M
    Naika Hokan; 1962 Dec; 9():539-45. PubMed ID: 13990979
    [No Abstract]   [Full Text] [Related]  

  • 19. [SOME CLINICAL ASPECTS OF DRUG RESISTANCE OF TUBERCLE BACILLI ISOLATED FROM PATIENTS WITH FIBRO-CAVERNOUS TUBERCULOSIS].
    MONDESHKI M; PASHMAKOV I
    Nauchni Tr Vissh Med Inst Sofiia; 1963; 42():33-42. PubMed ID: 14114104
    [No Abstract]   [Full Text] [Related]  

  • 20. [TREATMENT OF 140 PATIENTS HAVING BACILLI RESISTANT TO INH AND STREPTOMYCIN].
    CHICOU J
    Rev Tuberc Pneumol (Paris); 1964; 28():825-31. PubMed ID: 14236397
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.